Navigation Links
Provista Awards Agreement to Spheris
Date:11/20/2007

Spheris to be the First Provider of Clinical Documentation Technology,

Services to Provista

FRANKLIN, Tenn., Nov. 20 /PRNewswire/ -- Spheris has been selected as the first awarded supplier of medical transcription technology and services by Provista, one of the nation's leading group purchasing organizations. Under the parties' agreement, Spheris will provide Provista customers with a full range of clinical documentation technologies in addition to industry-leading outsource services.

"We're excited about our relationship with Spheris and to be able to offer our customers quality medical transcription technology and services from one of the clear leaders in the industry," said Russell Hall, vice president of operations for Provista.

Provista serves more than 10,000 health care and education organizations nationwide, providing solutions to help its customers improve financial performance.

With a global network of 5,500 medical language specialists providing 24- hour service, 365 days a year, Spheris believes its blended approach of service and technology is unique in the clinical documentation industry. Spheris offers a comprehensive, customizable platform for clinical documentation technologies that is available as a stand-alone solution or can be combined with either full or partial outsourcing.

The agreement allows Provista customers to receive preferred pricing on the Spheris Clarity(TM) platform for clinical documentation. Spheris Clarity is a fully integrated suite of applications that is designed to meet the diverse needs of physicians and departments across a health system enterprise. By enabling users to work on the same platform, Spheris Clarity improves the accessibility, interoperability, efficiency and productivity of the clinical documentation process.

"This partnership agreement will allow Provista customers not only to benefit from Spheris' unique Follow the Sun(SM) service and t
'/>"/>

SOURCE Spheris
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. U.S. Government Awards $15 Million Grant to GeoVax Labs HIV/AIDS Vaccine Program
2. CDC Awards NATT Funding to Improve Blood Clot Awareness
3. BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards
4. National Institutes of Health Awards $25.5M Contract to SRA
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
7. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
8. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
9. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
10. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
11. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Pa. , March 31, 2015   ... by integrating Mapi,s Medical Affairs and global Risk ... from a previously announced acquisition . ... operations are conducted by a global team that ... that have decades of experience in navigating complex ...
(Date:3/31/2015)... YORK , March 31, 2015  PlasmaTech ... company advancing protein biologic therapies and oncology supportive ... partner, Hanmi Pharmaceutical Co., Ltd ("Hanmi") (KSE: 128940) ... country,s Ministry of Food and Drug Safety ("MFDS") ... for MuGard, its oncology supportive-care treatment for the ...
(Date:3/31/2015)... 2015 This June 13th, a distinguished ... U.S and International Medical Schools will come together in ... the application of stem cell therapy in treatments and ... and funded by the Ocular Research Symposia Foundation, ... convening intimate meetings of top experts in the field ...
(Date:3/31/2015)... Diasome Pharmaceuticals, Inc. ( http://www.diasome.com ) has ... United States patent has recently been allowed for the ... Entitled “Lipid Construct for Delivery of Insulin to a ... to the use of Diasome’s proprietary Hepatocyte Directed Vesicles ... more effectively reach the liver’s metabolic cells, called hepatocytes. ...
Breaking Biology Technology:Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2
... May 17 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. ( ... company specialized in oncology and endocrinology, today announced that ... product designation from the Committee for Orphan Medicinal Products ... AEZS-108 for the treatment of ovarian cancer. AEZS-108, the ...
... , May 17 Soligenix, Inc. (OTC Bulletin Board: SNGX) ... results for the first quarter of 2010. , ... Soligenix,s revenues for the first quarter of 2010 ... the first quarter of 2009. The decreased revenues were primarily a result ...
... Sigma- Aldrich announces the retirement of David Julien , President – ... on his current role in January 2009 .  He served as President ... to January 2009 and before that in a number of senior ... , , , ...
Cached Biology Technology:Aeterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for AEZS-108 for the Treatment of Ovarian Cancer from the Committee for Orphan Medicinal Products of the European Medicines Agency 2Aeterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for AEZS-108 for the Treatment of Ovarian Cancer from the Committee for Orphan Medicinal Products of the European Medicines Agency 3Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments 2Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments 3Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments 4Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments 5Sigma-Aldrich (Nasdaq: SIAL) Announces Executive Management Changes: Retirement of David Julien and Promotion of Joseph Porwoll 2
(Date:3/16/2015)... 16, 2015 Between 16 ... present groundbreaking innovations in biometric identification at the ... .      (Photo: http://photos.prnewswire.com/prnh/20150316/735333 ... is well at the forefront: the company,s all ... in Germany . BiometricGate is ...
(Date:3/12/2015)... 2015 Beta Systems today ... access management (IAM) solution for a fixed price ... System,s new IAM package, customers benefit from the ... multiple IAM implementations across different industries. The new ... as any necessary services and consulting. It spans ...
(Date:3/11/2015)... 11, 2015   The Sync Project™ ... scientifically measure and harness music to improve health. ... and objective measurements of physiology, enabling the study ... in large populations. It is designed for medical ... perform rigorous studies and accelerate the discovery of ...
Breaking Biology News(10 mins):DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3
... ITHACA, NY Commercial apple growers in the northeastern ... and insect invasions to tree nutrition and crop load. ... of integrated fruit production (IFP) and organic fruit production ... alternative markets. In a recent issue of HortScience ...
... Today,s most common cultivated strawberry, the familiar Fragaria x vananassa ... a chance hybridization of two wild strawberry species in Europe ... characteristics of both species, including the larger, firmer fruit of ... fruit of F. virginiana . The fact that ...
... the most important fruit trees in the world. Citrus has ... than 4,000 years. Until now, however, the exact genetic origins ... ), lemon ( C. limon ), and grapefruit ( C. ... from China has published a study in the Journal of ...
Cached Biology News:Integrated, organic production systems evaluated for 'liberty' apple 2New research expands genetic base of cultivated strawberry 2Genetic origin of cultivated citrus determined 2
... Expansion Kit - Neurosphere is a system designed ... expansion as neurospheres in a serum free environment. ... Media Supplement, which has been optimized for neural ... . (1996) Genes & Development 10 :3129). ...
Request Info...
... RQ1 RNase-Free DNase is a ... single-stranded or double-stranded DNA to produce ... for use in applications where maintaining ... RQ1 DNase is qualified for use ...
... catalyzes the template-directed polymerization of nucleotides into ... Polymerase I possesses a 3?5 exonuclease activity ... rate during DNA replication, and also contains ... enzyme to replace nucleotides in the growing ...
Biology Products: